Hepatology

New research suggests that abnormal sleep duration may be associated with increased risk of chronic liver disease, particularly in people with metabolic risk factors.

A new global report shows uneven progress towards viral hepatitis elimination, with major gaps in diagnosis and treatment contributing to ongoing liver-related deaths.

New research has identified a liver-specific receptor, GPR110, as a key driver of sex-related differences in the progression of metabolic dysfunction-associated steatohepatitis.

New research calls for routine risk stratification of MASLD in people with obesity to detect and manage liver disease earlier.

A major UK trial launched to screen up to 42,000 adults in primary care for early liver disease using non-invasive testing.

Molecular profiling and matched targeted treatment significantly improved survival in advanced cholangiocarcinoma in a large Italian real-world study.

Patients who survive colorectal cancer face a sustained and increased risk of death from chronic liver disease and cirrhosis long after surgery, according to a large population-based analysis from the United States.